Skip to contentC
Core Scientific, Inc./tx
C
CORZZCore Scientific, Inc./tx Q2 2026 · 10-Q
Revenue$164.20M$164.20M+108.8% vs Q2 2025 Net Income-$1.16B-$1.16BN/M vs Q2 2025 EPS Diluted-$3.32-$3.32N/M vs Q2 2025 Gross Profit$70,044,000+1,293.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Core Scientific, Inc./tx · CIK 1839341 · Engraved from SEC EDGAR
Operating Cash Flowderived-$18,928,000N/M Free Cash Flowderived-$583,946,000N/M Margins · derivedGross margin42.7%+36.3 pt vs Q2 2025
Operating margin-47.8%−14.4 pt vs Q2 2025
Net margin-703.6%+487.8 pt vs Q2 2025
ended Jun 30, 2026 · filed Jul 28, 2026 · 28 d after period end